top of page

Partner specialised in

  • Computational Fluid Dynamics

  • Microfluidic flow Design and Simulation

#MIHfamily member
bionic surface technologies GmbH (BST)

Leading Edge in Microfluidic Device Simulation

BST is pivotal as the simulation and design partner for all microfluidic devices across various application fields in the project. Based in Graz, Austria, BST is a leader in Riblets, Computational Fluid Dynamics (CFD), and testing, with a high-performance data center and a wealth of experience in microstructures. Their responsibilities include both the design and simulation of microfluidic flows using CAD, CFD, and multiphysics simulation (flow, diffusion, heat transfer, and reaction kinetics). Additionally, BST plays a key role in standardizing the simulation process for microfluidic components and developing a standardized background library to accelerate future sensor development. This involves understanding new microfluidic designs' functionality and optimizing or redesigning existing designs.

Infographic of FluIDect's technology used in their SheroScan system to detect microbes on the spot.

FluIDect's Microfluidic Technology: Revolutionizing Industrial Microbial Detection

In the ever-evolving field of microfluidics, FluIDect is leading the way with groundbreaking technology that is set to revolutionize microbial detection and quality control in industrial environments. This innovation leverages the capabilities of microfluidic technology to introduce a novel sensor system designed for continuous, real-time monitoring of liquid products for specific microbial presence.

Image of DNA and Virus to showcase Scalable Molecular Diagnostics for SARS-CoV-2 with Advanced Microfluidic Chips.

Molecular Diagnostics for SARS-CoV-2

Sensor chip production for a molecular recognition platform in medical diagnostics in general and for SARS-CoV-2 diagnostics (both antibody and viral genetic material testing) in particular.

Image of the LUMICKS C-Trap optical tweezers platform integrated with microfluidic technology - won Funding from the NextGenMicrofluidics Prohect handeled by the Microfluidics Innovation Hub.

Advancing Single-Molecule Research with Dynamic Microfluidic Solutions

LUMICKS, a frontrunner in dynamic single-molecule (DSM) research, is revolutionizing our understanding of molecular mechanisms. With their cutting-edge technologies, they bridge the gap between molecular structure and function, providing unprecedented insights at the molecular level.

Image of Enzyre microfluidic Point-of-Care device for detection of multiple coagulation markers from a single blood drop.

Enzyre's Chemiluminescent Microfluidic Platform: A New Era in Personalized Diagnostics

Enzyre is revolutionizing personalized diagnostics with its groundbreaking chemiluminescent microfluidic platform, the EnzySystem. This innovative technology enables precise, near-patient testing of multiple coagulation markers from just a single drop of blood, transforming how bleeding disorders are managed and diagnosed.

Illustration of BioAnalyt’s iCheck Anemia device and its microfluidic cuvette in use.

Revolutionizing Iron Deficiency and Anemia Diagnostics: BioAnalyt's Pioneering Point-of-Care Device

BioAnalyt's iCheck Anemia project, developed in collaboration with the Microfluidics Innovation Hub, is creating a groundbreaking point-of-care diagnostic device for iron deficiency and anemia. This innovative microfluidic platform enables rapid, accurate, and user-friendly testing using a single drop of blood, revolutionizing early detection and treatment in both clinical and remote settings.

Illustration of SensipDx’s lab-on-a-cartridge device, showcasing its compact and efficient design for bacterial detection.

Revolutionizing Bacterial Detection - SensipDx Lab-on-a-Cartridge Technology

SensipDx's lab-on-a-cartridge technology, developed with the Microfluidics Innovation Hub, offers rapid and accurate on-site bacterial detection. This innovative system ensures high sensitivity and specificity, ideal for applications in food safety, healthcare, and more.

Photo of Novus Dx’s SepTec technology showcasing its components and the process of sepsis pathogen detection.

Revolutionizing Sepsis Diagnostics - The Novus Dx Technology

Novus Dx’s SepTec technology, developed with the Microfluidics Innovation Hub, revolutionizes sepsis diagnostics by providing rapid and accurate pathogen detection directly from whole blood in just 15 minutes. This near-patient system combines advanced microfluidic and electrochemical technologies to improve patient outcomes through faster, more reliable sepsis diagnosis.

Illustration of EXIAS Medical’s microfluidic chip and its integration into the blood analysis device.

Tackling Microfluidic Challenges with EXIAS Medical's Advanced Blood Analysis Device

EXIAS Medical, in partnership with the Microfluidics Innovation Hub, is advancing blood analysis with a microfluidic chip that measures critical blood parameters. This project tackles air bubble formation in microfluidic channels, enhancing sensor accuracy and ensuring reliable point-of-care diagnostics.

Contact us today and together we will evaluate which manufacturing process best suits your microfluidic needs! 

Are you ready to scale-up?

Contact us to discuss your microfluidic project requirements and objectives.


Partner Match

We connect you with the right manufacturing experts from our network.

We oversee the entire project, ensuring smooth coordination and timely delivery

Project Management

bottom of page